Find Lisdexamfetamine Dimesylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF DossiersDRUG PRODUCT COMPOSITIONS

116RELATED EXCIPIENT COMPANIES

180EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Vyvanse, 608137-33-3, Nrp-104, Lisdexamfetamine mesilate, Spd489, Tyvense
Molecular Formula
C17H33N3O7S2
Molecular Weight
455.6  g/mol
InChI Key
CETWSOHVEGTIBR-FORAGAHYSA-N
FDA UNII
SJT761GEGS

Lisdexamfetamine Dimesylate
A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
1 2D Structure

Lisdexamfetamine Dimesylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid
2.1.2 InChI
InChI=1S/C15H25N3O.2CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;2*1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);2*1H3,(H,2,3,4)/t12-,14-;;/m0../s1
2.1.3 InChI Key
CETWSOHVEGTIBR-FORAGAHYSA-N
2.1.4 Canonical SMILES
CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O
2.1.5 Isomeric SMILES
C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
SJT761GEGS
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dimesylate, Lis-dexamfetamine

2. Dimesylate, Lisdexamfetamine

3. Elvanse

4. Lis Dexamfetamine Dimesylate

5. Lis-dexamfetamine Dimesylate

6. Lisdexamfetamine

7. Nrp 104

8. Nrp-104

9. Nrp104

10. Vyvanse

2.3.2 Depositor-Supplied Synonyms

1. Vyvanse

2. 608137-33-3

3. Nrp-104

4. Lisdexamfetamine Mesilate

5. Spd489

6. Tyvense

7. Nrp104

8. Spd-489

9. Lisdexamfetamine Dimesylate [usan]

10. Lisdexamfetamine Dimesilate

11. Sjt761gegs

12. Lisdexamphetamine Dimesilate

13. L-lysine-d-amphetamine Dimesylate

14. Lisdexamfetamine Dimethanesulfonate

15. (2s)-2,6-diamino-n-[(1s)-1-methyl-2-phenylethyl]hexanamide Dimethanesulfonate

16. Lis-dexamfetamine Dimesylate

17. Lisdexamfetamine Mesilate (jan)

18. Lisdexamfetamine Dimesylate (usan)

19. Lisdexamfetamine Mesylate

20. Nrp 104

21. Lisdexamfetamine Mesilate [jan]

22. (2s)-2,6-diamino-n-[(2s)-1-phenylpropan-2-yl]hexanamide;methanesulfonic Acid

23. Unii-sjt761gegs

24. Venvanse

25. (2s)-2,6-diamino-n-((1s)-1-methyl-2-phenylethyl)hexanamide Dimethanesulfonate

26. Lys-amp

27. Spd 489

28. Lys-d-amp

29. Elvanse (tn)

30. Vyvanse (tn)

31. Schembl678421

32. Chembl1201178

33. Dtxsid60209653

34. Lisdexamfetamine Dimesylate Solution

35. Bcp24044

36. Akos030254940

37. Lisdexamfetamine Mesilate [mart.]

38. Ldx

39. Lisdexamfetamine Mesilate [who-dd]

40. Lisdexamfetamine Dimesylate [vandf]

41. D04747

42. Lisdexamfetamine Dimethanesulfonate [mi]

43. Lisdexamfetamine Dimesylate [orange Book]

44. 137l333

45. Q27289243

46. (2s)-2,6-diamino-n-((1s)-1-methyl-2-phenylethyl)hexanamide Dimethanesulphonate

47. Hexanamide, 2,6-diamino-n-((1s)-1-methyl-2-phenylethyl), (2s), Dimethanesulfonate

48. Hexanamide, 2,6-diamino-n-((1s)-1-methyl-2-phenylethyl), (2s), Dimethanesulphonate

49. Ldx;lisdexamfetamine Mesilate;lisdexamfetamine Mesylate;nrp 104;nrp-104;spd 489

50. Lisdexamfetamine Dimesylate Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 455.6 g/mol
Molecular Formula C17H33N3O7S2
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count9
Rotatable Bond Count8
Exact Mass455.17599275 g/mol
Monoisotopic Mass455.17599275 g/mol
Topological Polar Surface Area207 Ų
Heavy Atom Count29
Formal Charge0
Complexity344
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameLisdexamfetamine dimesylate
Drug LabelVyvanse (lisdexamfetamine dimesylate), a CNS stimulant,isa capsule for once-a-day oral administration. The chemical designation for lisdexamfetamine dimesylate is (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl] hexanamide dimethanesulfonate....
Active IngredientLisdexamfetamine dimesylate
Dosage FormCapsule
RouteOral
Strength30mg; 50mg; 60mg; 40mg; 70mg; 20mg
Market StatusTentative Approval
CompanyMylan Pharms; Amneal Pharms; Roxane

2 of 4  
Drug NameVyvanse
PubMed HealthAmphetamine (By mouth)
Drug ClassesAmphetamine
Drug LabelVyvanse (lisdexamfetamine dimesylate), a CNS stimulant,isa capsule for once-a-day oral administration. The chemical designation for lisdexamfetamine dimesylate is (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl] hexanamide dimethanesulfonate....
Active IngredientLisdexamfetamine dimesylate
Dosage FormCapsule
RouteOral
Strength30mg; 50mg; 60mg; 40mg; 20mg; 70mg
Market StatusPrescription
CompanyShire Development

3 of 4  
Drug NameLisdexamfetamine dimesylate
Drug LabelVyvanse (lisdexamfetamine dimesylate), a CNS stimulant,isa capsule for once-a-day oral administration. The chemical designation for lisdexamfetamine dimesylate is (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl] hexanamide dimethanesulfonate....
Active IngredientLisdexamfetamine dimesylate
Dosage FormCapsule
RouteOral
Strength30mg; 50mg; 60mg; 40mg; 70mg; 20mg
Market StatusTentative Approval
CompanyMylan Pharms; Amneal Pharms; Roxane

4 of 4  
Drug NameVyvanse
PubMed HealthAmphetamine (By mouth)
Drug ClassesAmphetamine
Drug LabelVyvanse (lisdexamfetamine dimesylate), a CNS stimulant,isa capsule for once-a-day oral administration. The chemical designation for lisdexamfetamine dimesylate is (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl] hexanamide dimethanesulfonate....
Active IngredientLisdexamfetamine dimesylate
Dosage FormCapsule
RouteOral
Strength30mg; 50mg; 60mg; 40mg; 20mg; 70mg
Market StatusPrescription
CompanyShire Development

4.2 Drug Indication

Treatment of Attention Deficit Hyperactivity Disorder (ADHD)


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Central Nervous System Stimulants

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)


Dopamine Uptake Inhibitors

Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Central Nervous System Stimulation [PE]; Central Nervous System Stimulant [EPC]

API SUPPLIERS

read-more
read-more

01

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Veranova

02

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Noramco

03

Cohance Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Cohance

04

Supriya Lifescience

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Supriya

05

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Veranova

06

Chattem Chemicals, Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PharmaVenue
Not Confirmed
arrow

Chattem Chemicals, Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Mallinckrodt Pharmaceuticals

Ireland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PharmaVenue
Not Confirmed
arrow

Mallinckrodt Pharmaceuticals

Ireland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Alkem Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PharmaVenue
Not Confirmed
arrow

Alkem Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Alkem Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PharmaVenue
Not Confirmed
arrow

Alkem Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Mallinckrodt Pharmaceuticals

Ireland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

PharmaVenue
Not Confirmed
arrow

Mallinckrodt Pharmaceuticals

Ireland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Veranova Lp

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2023-11-21

Pay. Date : 2023-10-12

DMF Number : 38874

Submission : 2023-10-20

Status : Active

Type : II

Veranova

02

Veranova Lp

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2020-01-28

Pay. Date : 2020-01-21

DMF Number : 22442

Submission : 2009-01-27

Status : Active

Type : II

Veranova

03

Noramco Llc

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2021-12-30

Pay. Date : 2021-11-18

DMF Number : 35645

Submission : 2021-11-23

Status : Active

Type : II

Noramco

04

PharmaVenue
Not Confirmed

05

PharmaVenue
Not Confirmed

06

PharmaVenue
Not Confirmed

06

PharmaVenue
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 20103

Submission : 2006-12-29

Status : Inactive

Type : II

blank

07

Chattem Chemicals Inc

U.S.A

USDMF

arrow
PharmaVenue
Not Confirmed

07

PharmaVenue
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-07-02

Pay. Date : 2018-05-22

DMF Number : 32289

Submission : 2018-05-18

Status : Active

Type : II

blank

08

Specgx Llc

Ireland

USDMF

arrow
PharmaVenue
Not Confirmed

08

Specgx Llc

Ireland
arrow
PharmaVenue
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32210

Submission : 2017-11-22

Status : Inactive

Type : II

blank

09

Specgx Llc

Ireland

USDMF

arrow
PharmaVenue
Not Confirmed

09

Specgx Llc

Ireland
arrow
PharmaVenue
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-07-28

Pay. Date : 2020-06-03

DMF Number : 34823

Submission : 2020-05-29

Status : Active

Type : II

blank

10

August Pharmaceuticals Llc

Country

USDMF

arrow
PharmaVenue
Not Confirmed

10

August Pharmaceuticals Llc

Country
arrow
PharmaVenue
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35754

Submission : 2021-05-28

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

Lisdexamphetamine dimesilate INH

Date of Issue : 2022-09-01

Valid Till : 2025-07-28

Written Confirmation Number : WC-0046

Address of the Firm : Plot No. E-21, E-22/1, MIDC, Mahad, Dist. Raigad-402 309, Maharashtra

blank

02

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

Lisdexamfetamine Dimesylate IH

Date of Issue : 2022-06-03

Valid Till : 2025-05-27

Written Confirmation Number : WC-0003

Address of the Firm : Vill.- Bhagwanpur, Barwala Road, Near Dera Bassi, Distt.- SAS Nagar (Mohali), Pu...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 49812-0186

Start Marketing Date : 2012-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Veranova

02

Noramco, LLC

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 51634-2058

Start Marketing Date : 2021-12-10

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Noramco

03

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 17180-1100

Start Marketing Date : 2007-02-23

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (18kg/18kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

04

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 59116-3012

Start Marketing Date : 2014-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 59116-3010

Start Marketing Date : 2012-10-26

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 59116-3011

Start Marketing Date : 2013-07-02

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 59116-3013

Start Marketing Date : 2016-10-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 61960-0300

Start Marketing Date : 2018-03-21

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 65392-0118

Start Marketing Date : 2007-02-23

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

10

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

LISDEXAMFETAMINE DIMESYLATE

NDC Package Code : 53834-401

Start Marketing Date : 2023-10-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Veranova

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

Lisdexamfetamine Dimesylate

About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...

Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the challenges of the global healthcare industry, and nurturing long-standing, trusted customer relationships. Operating within two divisions, Generics and Originators, we deliver a differentiated service offering to pharma and biotech customers for every stage in the drug development lifecycle. Macfarlan Smith Limited is trading as Veranova in the United Kingdom.
Veranova

02

Noramco

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

Lisdexamfetamine Dimesylate

About the Company : Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and ma...

Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and manufacturing, Noramco offers services like supply-chain integration for high-purity controlled substances, efficient routes to APIs, analytical data, stability studies, regulatory help, formulation-friendly particle size grades, extended technical packages, DEA-compliant security and production capacity from kilos to multi-ton supply. Noramco also offers world-class supply security for controlled substances, from Schedule I to Schedule III.
Noramco

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Flag India
Digital Content Digital Content

Lisdexamfetamine Dimesylate

About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...

Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
Cohance

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content

Lisdexamfetamine

About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Su...

Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
Supriya

05

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

Lisdexamfetamine Dimesylate

About the Company : Back in the year 1973, a team of individuals came up with such an idea – The idea called Alkem. Looking back at our 5 decades, illustrious journey, that one small idea has Not on...

Back in the year 1973, a team of individuals came up with such an idea – The idea called Alkem. Looking back at our 5 decades, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 40 countries. 29% of our revenue is generated via offshore sales and it has consistently been ranked amongst the top ten pharmaceutical companies in India. They have 20 manufacturing facilities at multiple locations in India and the United States of America.
blank

06

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

Lisdexamfetamine Dimesylate

About the Company : Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the ...

Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
blank

07

PharmaVenue
Not Confirmed
arrow
arrow
PharmaVenue
Not Confirmed

Lisdexamfetamine

About the Company : At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biot...

At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biotransformation, we develop fully backward-integrated platforms, creating a first-mover advantage in global markets. A leading manufacturer of Schedule-1 and Schedule-2 substances, Embio excels in controlled substances, intermediates, and chiral molecules. Our US-FDA, PMDA, KFDA, COFEPRIS, and WHO-GMP-approved facility in MIDC Mahad serves 70+ countries, including top 10 pharma companies.
blank

08

J&H CHEM

China
PharmaVenue
Not Confirmed
arrow

J&H CHEM

China
arrow
PharmaVenue
Not Confirmed

Lisdexamfetamine Dimesylate

About the Company : J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Valu...

J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Value-added customer services, for diversified range products of chemicals, pharmaceuticals, and specialities. As a highly customer-oriented enterprise, we always believe "Customer first, service foremost", put forward innovation, continuously improve pipeline, integrate our broad range of products and services with our technical expertise, customise a competitive package to meet our customers' specific needs.
blank

09

Lee Pharma

India
PharmaVenue
Not Confirmed
arrow

Lee Pharma

India
arrow
PharmaVenue
Not Confirmed

Lisdexamfetamine Dimesylate

About the Company : Founded in 1997, Lee Pharma Limited has transformed from a small venture into a global leader in the pharmaceutical industry. Our journey began with a commitment to providing affor...

Founded in 1997, Lee Pharma Limited has transformed from a small venture into a global leader in the pharmaceutical industry. Our journey began with a commitment to providing affordable and high-quality healthcare solutions. Through advanced research, modern manufacturing, and a strong emphasis on quality, we are dedicated to producing medicines that enhance lives. Lee Pharma is a research-focused company that prioritizes the development, synthesis, and commercialization of high-quality Active Pharmaceutical Ingredients (APIs), intermediate chemicals, and finished formulations.
blank

10

SM BIOMED

Malaysia
PharmaVenue
Not Confirmed
arrow

SM BIOMED

Malaysia
arrow
PharmaVenue
Not Confirmed

Lisdexamfetamine Dimesylate

About the Company : Established in 1991, SM Biomed is a joint venture company pioneering the manufacture of API (active pharmaceutical ingredients) products in Malaysia. Company has grown several fold...

Established in 1991, SM Biomed is a joint venture company pioneering the manufacture of API (active pharmaceutical ingredients) products in Malaysia. Company has grown several folds as a market leader in the manufacture of macrolide antibiotics. Quality in the products & excellent service to our clients has been the essence of our success. Asia’s largest producer and exporter of Synthetic Macrolide antibiotics.Malaysia’s largest exporter of pharmaceuticals. We shall learn, we shall seek, attain higher peaks, soar and grow as a major force for the millennium.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Lisdexamfetamine Dimesylate Capsules are a federally controlled substance (CII) used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and other indications and currently are on the FDA's drug shortage list.


Lead Product(s): Lisdexamfetamine Dimesylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Vyvanse-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 31, 2023

blank

01

PharmaVenue
Not Confirmed
PharmaVenue
Not Confirmed

Details : Lisdexamfetamine Dimesylate Capsules are a federally controlled substance (CII) used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and other indications and currently are on the FDA's drug shortage list.

Product Name : Vyvanse-Generic

Product Type : Controlled Substance

Upfront Cash : Inapplicable

August 31, 2023

blank

Details:

Lisdexamfetamine dimesylate capsules, for oral use is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder and Moderate to Severe Binge Eating Disorder (BED) in adults.


Lead Product(s): Lisdexamfetamine Dimesylate

Therapeutic Area: Psychiatry/Psychology Brand Name: Vyvanse-Generic

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 09, 2023

blank

02

PharmaVenue
Not Confirmed
PharmaVenue
Not Confirmed

Details : Lisdexamfetamine dimesylate capsules, for oral use is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder and Moderate to Severe Binge Eating Disorder (BED) in adults.

Product Name : Vyvanse-Generic

Product Type : Controlled Substance

Upfront Cash : Inapplicable

June 09, 2023

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - 10MG

USFDA APPLICATION NUMBER - 21977

read-more

DOSAGE - CAPSULE;ORAL - 20MG

USFDA APPLICATION NUMBER - 21977

read-more

DOSAGE - CAPSULE;ORAL - 30MG

USFDA APPLICATION NUMBER - 21977

read-more

DOSAGE - CAPSULE;ORAL - 40MG

USFDA APPLICATION NUMBER - 21977

read-more

DOSAGE - CAPSULE;ORAL - 50MG

USFDA APPLICATION NUMBER - 21977

read-more

DOSAGE - CAPSULE;ORAL - 60MG

USFDA APPLICATION NUMBER - 21977

read-more

DOSAGE - CAPSULE;ORAL - 70MG

USFDA APPLICATION NUMBER - 21977

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Empty Capsules

read-more
read-more

Coating Systems & Additives

read-more
read-more

Parenteral

read-more
read-more

Coloring Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Solubilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 608137-33-3 / Lisdexamfetamine Dimesylate API manufacturers, exporters & distributors?

Lisdexamfetamine Dimesylate manufacturers, exporters & distributors 1

17

PharmaCompass offers a list of Lisdexamfetamine Dimesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lisdexamfetamine Dimesylate manufacturer or Lisdexamfetamine Dimesylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lisdexamfetamine Dimesylate manufacturer or Lisdexamfetamine Dimesylate supplier.

PharmaCompass also assists you with knowing the Lisdexamfetamine Dimesylate API Price utilized in the formulation of products. Lisdexamfetamine Dimesylate API Price is not always fixed or binding as the Lisdexamfetamine Dimesylate Price is obtained through a variety of data sources. The Lisdexamfetamine Dimesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Lisdexamfetamine Dimesylate

Synonyms

Vyvanse, 608137-33-3, Nrp-104, Lisdexamfetamine mesilate, Spd489, Tyvense

Cas Number

608137-33-3

Unique Ingredient Identifier (UNII)

SJT761GEGS

About Lisdexamfetamine Dimesylate

A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.

Vyvanse Manufacturers

A Vyvanse manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vyvanse, including repackagers and relabelers. The FDA regulates Vyvanse manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vyvanse API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Vyvanse manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Vyvanse Suppliers

A Vyvanse supplier is an individual or a company that provides Vyvanse active pharmaceutical ingredient (API) or Vyvanse finished formulations upon request. The Vyvanse suppliers may include Vyvanse API manufacturers, exporters, distributors and traders.

click here to find a list of Vyvanse suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Vyvanse USDMF

A Vyvanse DMF (Drug Master File) is a document detailing the whole manufacturing process of Vyvanse active pharmaceutical ingredient (API) in detail. Different forms of Vyvanse DMFs exist exist since differing nations have different regulations, such as Vyvanse USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Vyvanse DMF submitted to regulatory agencies in the US is known as a USDMF. Vyvanse USDMF includes data on Vyvanse's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vyvanse USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Vyvanse suppliers with USDMF on PharmaCompass.

Vyvanse WC

A Vyvanse written confirmation (Vyvanse WC) is an official document issued by a regulatory agency to a Vyvanse manufacturer, verifying that the manufacturing facility of a Vyvanse active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vyvanse APIs or Vyvanse finished pharmaceutical products to another nation, regulatory agencies frequently require a Vyvanse WC (written confirmation) as part of the regulatory process.

click here to find a list of Vyvanse suppliers with Written Confirmation (WC) on PharmaCompass.

Vyvanse NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vyvanse as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Vyvanse API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Vyvanse as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Vyvanse and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vyvanse NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Vyvanse suppliers with NDC on PharmaCompass.

Vyvanse GMP

Vyvanse Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Vyvanse GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vyvanse GMP manufacturer or Vyvanse GMP API supplier for your needs.

Vyvanse CoA

A Vyvanse CoA (Certificate of Analysis) is a formal document that attests to Vyvanse's compliance with Vyvanse specifications and serves as a tool for batch-level quality control.

Vyvanse CoA mostly includes findings from lab analyses of a specific batch. For each Vyvanse CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Vyvanse may be tested according to a variety of international standards, such as European Pharmacopoeia (Vyvanse EP), Vyvanse JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vyvanse USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty